What I'm referring to, of course, is the stock compensation plans that provide stock-basd compensation to executives and other employees. Voting for those plans and not expecting them to sell those shares at some point is a little hypocritical.
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC. We're on Twitter at BiotechStockRsr